Zebrafish as a Model for Parkinson?s Disease - Mohamed, Wael; (ed.) - Prospero Internet Bookshop

Zebrafish as a Model for Parkinson?s Disease
 
Product details:

ISBN13:9781032515779
ISBN10:1032515775
Binding:Hardback
No. of pages:314 pages
Size:297x210 mm
Weight:739 g
Language:English
Illustrations: 8 Illustrations, black & white; 32 Illustrations, color; 6 Halftones, black & white; 26 Halftones, color; 2 Line drawings, black & white; 6 Line drawings, color; 20 Tables, black & white
0
Category:

Zebrafish as a Model for Parkinson?s Disease

 
Edition number: 1
Publisher: CRC Press
Date of Publication:
 
Normal price:

Publisher's listprice:
GBP 180.00
Estimated price in HUF:
86 940 HUF (82 800 HUF + 5% VAT)
Why estimated?
 
Your price:

78 246 (74 520 HUF + 5% VAT )
discount is: 10% (approx 8 694 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
  Piece(s)

 
Short description:

The increasing demand for innovative techniques arises from the lack of effective, and patient-friendly therapies for neurodegenerative disorders. With this objective in mind, the chapters of the book are structured to offer a thorough insight into recent advancements in utilizing the Zebrafish as a model for studying Parkinson's disease.

Long description:

The increasing demand for innovative techniques arises from the lack of safe, effective, and patient-friendly therapies for neurodegenerative disorders. With this objective in mind, the chapters of the book are structured to offer a thorough insight into recent advancements in utilizing the zebrafish (ZF) as a model for studying Parkinson?s disease (PD). This book aims to present readers with a comprehensive understanding of the clinical application of the ZF model in treating PD, encompassing the latest developments, challenges, safety considerations, toxicity issues, regulatory aspects, future potential, and limitations. Individuals in academia, the scientific community, business, and education seeking a more effective approach to target the brain stand to benefit from this resource.


Key Features



  • Provides a comparative perspective of the zebrafish?Parkinson?s disease model

  • Highlights the restrictions of available medicines

  • Describes biochemical and histopathological characteristics, advantages, and disadvantages of this model

  • Emphasizes distinct facets of histopathology

  • Presents advances and developments of the future potential perspectives
Table of Contents:

SECTION-I: FROM AQUARIUM TO LAB: THE RISE OF ZEBRAFISH AS A MODEL ORGANISM. 1. General Methods For Zebrafish Care. 2. Breeding of Zebrafish and its life cycle. 3. Neurobehavioral assessment of Zebrafish. 4. Cellular and Genetic Methods in Zebrafish. 5. Repeated blood sampling from an adult Danio rerio. 6. Zebrafish Culture. 7. Calcium Imaging of Neuronal Activity in Free-Swimming Larval Zebrafish. 8. Anesthesia, Analgesia, and Euthanasia of the Laboratory Zebrafish. 9. Zebrafish Guidelines, Policies and Regulations in Research. SECTION-II: ZEBRAFISH AS A MODEL OF PARKINSON?S DISEASE.10. The Role of Neurotransmitters in the Pathophysiology of Parkinson's Disease. 11. Diagnosis and Biomarkers of PD. 12. Parkinson's Disease Models Pros and Cons. 13. Pharmacotherapy of PD and their limitations. 14. Induction and VALIDATION OF ZF model of PD. 15. Zebra fish as a model for a novel Parkinson?s disease protective natural Product. 16. Zebrafish model for studying microbiome associated Parkinson?s Disease. 17. Transgenic zebrafish reporter lines for in vivo studying of Parkinson?s disease. 18. Interplay of neurodenegrative disorders in zebrafish:  unlocking the mystery. 19. Smart Capsule and Edible Bird's Nest: Charting New Frontiers in Parkinson?s Disease Defense-An Experimental Protocol Perspective. 20. Zebrafish Model for Drug Discovery and Screening.